Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Mohamad S Alabdaljabar1, Emily E Cendrowski2, Rick A Nishimura2

  • 1Departments of Internal Medicine (M.S.A.), Mayo Clinic, Rochester, MN.

Insights

Alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy effectively reduces left ventricular outflow tract (LVOT) gradients and left atrial (LA) pressures. Key predictors of survival include baseline LA pressure, LVOT gradient reduction, and pulse pressure increase post-procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Alcohol septal ablation (ASA) is a minimally invasive treatment for drug-refractory obstructive hypertrophic cardiomyopathy (oHCM).
  • Detailed assessment of pressure changes and predictors of mortality and procedure success in ASA are not well defined.

Purpose of the Study:

  • To evaluate pressure changes following transseptal ASA.
  • To identify predictors of mortality and procedure success in patients undergoing ASA.

Main Methods:

  • Single-center study including 156 patients undergoing transseptal ASA.
  • Assessment of pressure changes (LA pressure, LVOT gradient, aortic pulse pressure) pre- and post-procedure.
  • Survival analysis using Kaplan-Meier and Cox regression to identify predictors of mortality.

Main Results:

  • Post-ASA, left atrial (LA) pressure and left ventricular outflow tract (LVOT) gradient decreased, while aortic pulse pressure (PP) increased.
  • Lower baseline mean LA pressure, greater LVOT gradient reduction (>82%), and greater PP increase (>19%) were associated with superior survival.
  • Predictors of mortality included higher baseline mean LA pressure, higher residual LVOT gradient, and lower LVOT gradient reduction percentage.

Conclusions:

  • ASA acutely decreases LVOT gradient and LA pressures while increasing aortic PP.
  • Mean LA pressure, LVOT gradient reduction, and PP increase are significant predictors of survival post-ASA.
  • These hemodynamic variables are crucial for procedural guidance and patient selection in ASA.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15